HCM

Chi-Med
NASDAQ

Real-time Quotes | Nasdaq Last Sale

18.55
+0.90
+5.10%
Opening 10:49 04/06 EDT
OPEN
18.50
PREV CLOSE
17.65
HIGH
18.75
LOW
18.35
VOLUME
16.71K
TURNOVER
--
52 WEEK HIGH
32.55
52 WEEK LOW
14.74
MARKET CAP
2.56B
P/E (TTM)
-232.7478
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 9 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average HCM stock price target is 35.46 with a high estimate of 45.00 and a low estimate of 24.70.

EPS

HCM News

More
  • Week In Review: Signs Of Life After Coronavirus - China Biopharma Scores $721 Million In Deals
  • Seeking Alpha - Article · 22h ago
  • Chi-Med launches mid-stage HMPL-453 study in malignant mesothelioma
  • Seeking Alpha - Article · 6d ago
  • Chi-Med Initiates a Phase II Trial of HMPL-453 in Patients with Advanced Malignant Mesothelioma in China
  • GlobeNewswire · 6d ago
  • Deutsche Bank's Depositary Receipts Virtual Investor Conference presentations now available for On-Demand Viewing
  • CNW Group · 03/26 13:35

Industry

Pharmaceuticals
+2.81%
Pharmaceuticals & Medical Research
+3.06%

Hot Stocks

Symbol
Price
%Change

About HCM

Hutchison China Meditech Limited is an investment holding company principally engaged in the manufacture and sale of drugs. Along with subsidiaries, the Company operates its business through two segments. The Manufacturing Business segment is engaged in the manufacture and distribution of drug products. The Distribution Business segment provides sales and marketing services to pharmaceutical manufacturers. The Company's products include prescription and over the counter (OTC) pharmaceuticals such as banlangen, fu fang dan shen tablets and shexiang baoxin pills and others, and consumer health products. In addition, the Company also develops targeted therapeutics and immunotherapies for oncology and autoimmune diseases.
More

Webull offers kinds of Hutchison China MediTech Limited stock information, including NASDAQ:HCM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HCM stock news, and many more online research tools to help you make informed decisions.